Breast cancer brachytherapy
•
3 likes•721 views
Arizona Breast Cancer Specialists offers brachytherapy, also known as internal radiation therapy, as an alternative to traditional external beam radiation therapy for early stage breast cancer. Brachytherapy involves placing radioactive sources inside or near the breast and takes only 5 days to complete, compared to 6-7 weeks for external beam radiation. The clinic was founded by Dr. Robert Kuske who pioneered breast brachytherapy techniques and is led by Dr. Kuske and Dr. Coral Quiet, who together have over 40 years of experience treating breast cancer.
Report
Share
Report
Share
Download to read offline
Recommended
Brachytherapy in breast cancer
This document discusses brachytherapy for breast cancer, including indications and treatment modalities. It notes that brachytherapy allows higher doses to be delivered to smaller target volumes, shortening treatment time and reducing tumor repopulation. Prospective randomized trials show lumpectomy with radiation improves local control over lumpectomy alone. Accelerated partial breast irradiation (APBI) delivers radiation to a limited region after breast-conserving surgery in 4-5 days instead of 3-7 weeks for whole breast irradiation (WBI), improving quality of life. Patient selection criteria for APBI are discussed. Brachytherapy is the most conformal radiation option, minimizing dose to normal tissues. Boost radiation after WBI improves local control and cos
New techniques in breast radiotherapy
This document discusses new techniques in breast radiotherapy, including partial breast irradiation (PBI). It describes several techniques for PBI including interstitial brachytherapy using catheters, intracavitary brachytherapy using the Mammosite device, and 3D conformal external beam radiation therapy. The document highlights the potential benefits of PBI such as reduced treatment time from 6 weeks to 1 week, decreased toxicity, and increased utilization of breast conserving therapy. However, it also notes limitations including the need for additional surgery with some techniques and the lack of long-term data comparing PBI to standard whole breast irradiation.
Radiotherapy breast
The document discusses breast-conserving treatment for early-stage breast cancer. Breast-conserving treatment, including wide local excision of the tumor, axillary lymph node dissection, and breast irradiation, is now the standard of care for most women with early-stage invasive breast cancer. Ideal candidates for breast-conserving treatment have unicentric primary tumors less than 4-5 cm in diameter. Contraindications include positive margins, advanced or multicentric disease, pregnancy, and prior radiation. The addition of a radiation boost to the tumor bed after whole breast irradiation reduces the risk of local recurrence. Hypofractionated regimens have been shown to be as effective as conventional fractionation with shorter treatment times.
Apbi
Accelerated partial breast irradiation (APBI) delivers radiation to only the area around the tumor bed after breast-conserving surgery rather than the entire breast. Several techniques for APBI exist including interstitial brachytherapy, intracavitary brachytherapy, intraoperative radiation therapy, and external beam radiotherapy. Studies show local recurrence rates and cosmetic outcomes with APBI are comparable to whole breast irradiation, though longer follow up is still needed before APBI can be considered the new standard of care for early-stage breast cancer patients.
Updates in Radiotherapy for Breast Cancer
This document summarizes advances in radiotherapy for breast cancer over the past 50 years. It discusses how radiotherapy combined with surgery and systemic therapies has improved local control and survival outcomes. Modern techniques like 3D conformal radiotherapy and intensity-modulated radiotherapy can reduce acute side effects compared to older 2D techniques. Ongoing research is exploring hypofractionated whole breast irradiation and accelerated partial breast irradiation to reduce treatment time. Large trials are still needed to establish optimal radiotherapy approaches.
Brachytherapy in breast cancer
Brachytherapy is an effective alternative to whole breast external beam radiation therapy for delivering targeted radiation in breast cancer treatment. There are two main types of brachytherapy used - interstitial brachytherapy which involves implanting catheters directly into the breast tissue, and intracavitary brachytherapy which uses balloon or strut-based applicators placed in the lumpectomy cavity. Brachytherapy provides conformal radiation delivery and spares surrounding healthy tissue. It is commonly used as accelerated partial breast irradiation for early stage disease, but can also be used as neoadjuvant treatment prior to surgery or as salvage therapy for local recurrence after breast conservation. Critical factors for successful brachytherapy
Accelerated partial breast irradiation
Accelerated partial breast irradiation is an alternative to whole breast irradiation in carcinoma breast patients Post breast conserving surgery with equivalent outcome, less duration & less burden on the patient.
Radiotherapy in Early stage invasive breast carcinoma
This document discusses radiotherapy treatment for early stage invasive breast carcinoma. It provides details on diagnostic workup, treatment options including mastectomy and breast conserving therapy. It describes different types of mastectomies and details on breast conserving therapy including whole breast radiotherapy and tumor bed boost. It summarizes key studies showing no overall survival advantage of mastectomy over breast conserving therapy with radiotherapy and the benefit of tumor bed boost in reducing local recurrence. It also discusses techniques for delivering radiotherapy to different treatment volumes.
Recommended
Brachytherapy in breast cancer
This document discusses brachytherapy for breast cancer, including indications and treatment modalities. It notes that brachytherapy allows higher doses to be delivered to smaller target volumes, shortening treatment time and reducing tumor repopulation. Prospective randomized trials show lumpectomy with radiation improves local control over lumpectomy alone. Accelerated partial breast irradiation (APBI) delivers radiation to a limited region after breast-conserving surgery in 4-5 days instead of 3-7 weeks for whole breast irradiation (WBI), improving quality of life. Patient selection criteria for APBI are discussed. Brachytherapy is the most conformal radiation option, minimizing dose to normal tissues. Boost radiation after WBI improves local control and cos
New techniques in breast radiotherapy
This document discusses new techniques in breast radiotherapy, including partial breast irradiation (PBI). It describes several techniques for PBI including interstitial brachytherapy using catheters, intracavitary brachytherapy using the Mammosite device, and 3D conformal external beam radiation therapy. The document highlights the potential benefits of PBI such as reduced treatment time from 6 weeks to 1 week, decreased toxicity, and increased utilization of breast conserving therapy. However, it also notes limitations including the need for additional surgery with some techniques and the lack of long-term data comparing PBI to standard whole breast irradiation.
Radiotherapy breast
The document discusses breast-conserving treatment for early-stage breast cancer. Breast-conserving treatment, including wide local excision of the tumor, axillary lymph node dissection, and breast irradiation, is now the standard of care for most women with early-stage invasive breast cancer. Ideal candidates for breast-conserving treatment have unicentric primary tumors less than 4-5 cm in diameter. Contraindications include positive margins, advanced or multicentric disease, pregnancy, and prior radiation. The addition of a radiation boost to the tumor bed after whole breast irradiation reduces the risk of local recurrence. Hypofractionated regimens have been shown to be as effective as conventional fractionation with shorter treatment times.
Apbi
Accelerated partial breast irradiation (APBI) delivers radiation to only the area around the tumor bed after breast-conserving surgery rather than the entire breast. Several techniques for APBI exist including interstitial brachytherapy, intracavitary brachytherapy, intraoperative radiation therapy, and external beam radiotherapy. Studies show local recurrence rates and cosmetic outcomes with APBI are comparable to whole breast irradiation, though longer follow up is still needed before APBI can be considered the new standard of care for early-stage breast cancer patients.
Updates in Radiotherapy for Breast Cancer
This document summarizes advances in radiotherapy for breast cancer over the past 50 years. It discusses how radiotherapy combined with surgery and systemic therapies has improved local control and survival outcomes. Modern techniques like 3D conformal radiotherapy and intensity-modulated radiotherapy can reduce acute side effects compared to older 2D techniques. Ongoing research is exploring hypofractionated whole breast irradiation and accelerated partial breast irradiation to reduce treatment time. Large trials are still needed to establish optimal radiotherapy approaches.
Brachytherapy in breast cancer
Brachytherapy is an effective alternative to whole breast external beam radiation therapy for delivering targeted radiation in breast cancer treatment. There are two main types of brachytherapy used - interstitial brachytherapy which involves implanting catheters directly into the breast tissue, and intracavitary brachytherapy which uses balloon or strut-based applicators placed in the lumpectomy cavity. Brachytherapy provides conformal radiation delivery and spares surrounding healthy tissue. It is commonly used as accelerated partial breast irradiation for early stage disease, but can also be used as neoadjuvant treatment prior to surgery or as salvage therapy for local recurrence after breast conservation. Critical factors for successful brachytherapy
Accelerated partial breast irradiation
Accelerated partial breast irradiation is an alternative to whole breast irradiation in carcinoma breast patients Post breast conserving surgery with equivalent outcome, less duration & less burden on the patient.
Radiotherapy in Early stage invasive breast carcinoma
This document discusses radiotherapy treatment for early stage invasive breast carcinoma. It provides details on diagnostic workup, treatment options including mastectomy and breast conserving therapy. It describes different types of mastectomies and details on breast conserving therapy including whole breast radiotherapy and tumor bed boost. It summarizes key studies showing no overall survival advantage of mastectomy over breast conserving therapy with radiotherapy and the benefit of tumor bed boost in reducing local recurrence. It also discusses techniques for delivering radiotherapy to different treatment volumes.
Radiotherapy In Early Breast Cancer
This document summarizes the use of radiotherapy in early breast cancer treatment. It discusses how breast-conserving therapy with radiotherapy is as effective as mastectomy, and how radiotherapy reduces local recurrence when used as part of breast-conserving surgery for ductal carcinoma in situ. It also describes different radiotherapy techniques for early invasive breast cancer including whole breast irradiation, tumor bed boosts, and accelerated partial breast irradiation.
RT breast apbi
1) The document discusses various techniques for radiation therapy treatment planning and delivery for breast cancer, including tangential field planning, supraclavicular field matching, electron boosts, and accelerated partial breast irradiation.
2) Techniques for accelerated partial breast irradiation discussed include multi-catheter interstitial brachytherapy, balloon-based brachytherapy using devices like Mammosite, and external beam radiation therapy.
3) Factors that determine suitability for accelerated partial breast irradiation include patient age, tumor size and characteristics, and nodal involvement. Dosage schedules and advantages and disadvantages of different techniques are also reviewed.
RADIOTHERAPY FOR BREAST CANCER
1. The document discusses locally advanced breast cancer and the role of radiotherapy. It outlines the anatomy, target volumes, organs at risk and response assessment using tools like MRI.
2. Postmastectomy radiotherapy can reduce the risk of local recurrence by 72% and increase survival rates. The risk of local recurrence is higher with larger tumor size and more positive lymph nodes.
3. The use of neoadjuvant chemotherapy and radiotherapy after mastectomy further reduces the risk of local-regional recurrence compared to no radiotherapy, especially in patients with more advanced clinical stage.
ADJUTANT RADIOTHERAPY IN BREAST CANCER
This document discusses the evidence for adjuvant radiotherapy in breast cancer treatment. It finds that radiotherapy after breast-conserving surgery or mastectomy significantly reduces the risk of local recurrence and improves overall survival. For patients undergoing breast-conserving surgery, radiotherapy reduces the 10-year cumulative incidence of recurrence in the ipsilateral breast from 39.2% to 14.3%. Post-mastectomy radiotherapy is recommended for patients with ≥4 positive lymph nodes or 1-3 positive lymph nodes with high-risk features, as it lowers the risk of locoregional recurrence and improves overall survival. The timing, techniques, target volumes, and indications for radiotherapy are also outlined based on clinical evidence and guidelines.
Radiotherapy Breast Cancer
Radiotherapy is commonly used to treat breast cancer. Proper patient positioning and immobilization are crucial to accurately deliver the prescribed radiation dose while sparing surrounding healthy tissues. Treatment typically involves two tangential photon beams shaped to the breast tissue. Three-dimensional conformal radiotherapy may improve dose uniformity in the breast and reduce radiation exposure to the heart and lungs. Intensity-modulated radiation therapy provides further dosimetric advantages such as enhanced dose homogeneity and organ sparing, though it may also increase low-dose exposure. Forward-planned IMRT techniques like field-in-field are commonly used for breast radiotherapy due to benefits such as improved dosimetry and reduced planning/treatment time compared to inverse planning.
2012_Breast Cancer and Coronary Artery Disease
This document discusses radiation therapy for breast cancer and its potential effects on the heart and coronary arteries. It provides an overview of the pathophysiology of radiation-induced cardiac toxicity, including microangiopathy of small vessels, macroangiopathy of coronary arteries, and fibrosis. It also summarizes several studies that found increased risks of ischemic heart disease, pericarditis, and valvular disease in patients receiving left-sided breast radiation compared to right-sided radiation. Newer radiation techniques using methods like deep inspiration breath hold and intensity-modulated radiation therapy can help reduce radiation doses to the heart.
Breast HDR interstitial brachytherapy
This document provides information on breast interstitial brachytherapy workshop presented by Ali Bagheri M.D. and Cynthia Aristei M.D. It discusses clinical aspects of accelerated partial breast irradiation (APBI) including patient selection, techniques such as multi-catheter interstitial brachytherapy and balloon-based brachytherapy. It also covers target delineation, dose-fractionation schedules, dose constraints, and provides an example case of a 65 year old female who underwent lumpectomy and is a candidate for APBI using interstitial brachytherapy based on her pathology report and imaging.
San Antonio Breast Cancer Symposium 2007 Highlights – Radiotherapy
The document summarizes several studies presented at the 2007 San Antonio Breast Cancer Symposium on radiotherapy techniques:
1) The Cambridge Breast IMRT Trial found IMRT significantly reduced hot and cold spots compared to standard radiotherapy for breast cancer.
2) A trial of 224 patients found prone positioning enabled better sparing of the heart and lungs in most cases compared to supine.
3) The START trials found hypofractionated whole breast radiotherapy schedules were as effective as standard schedules with no increase in long-term morbidity.
intrabeam intraoperative radiotherapy
The document discusses intrabeam intraoperative radiotherapy (IORT) for breast cancer. It summarizes the TARGIT-A clinical trial which found IORT using the INTRABEAM system to be non-inferior to whole breast external beam radiotherapy for selected early-stage breast cancer patients. The INTRABEAM system delivers a targeted single fraction of low-energy X-rays directly to the tumor bed during lumpectomy surgery, shortening treatment time compared to the standard 5-6 weeks of external beam radiotherapy. The technique aims to sterilize the tumor bed while sparing surrounding healthy tissue from radiation exposure.
Marc Wigoda : Radiotherapy of the Axilla in Early Breast Cancer : When and H...
Marc Wigoda : Radiotherapy of the Axilla in Early Breast Cancer : When and H...breastcancerupdatecongress
1. Radiotherapy of the axilla can be an effective alternative to axillary lymph node dissection for early breast cancer patients who are sentinel lymph node positive. Two randomized trials found similar survival and recurrence rates with radiotherapy compared to lymph node dissection.
2. Radiotherapy fields may be limited to just the breast tissue and do not require an additional "axillary/supraclavicular" field. Classical tangential fields that treat 50-80% of axillary nodes are sufficient.
3. For sentinel lymph node positive patients, radiotherapy results in fewer side effects like lymphedema compared to lymph node dissection. Radiotherapy is as effective as surgery for these patients.radiation therapy in ca breast
EBCTCG METAANALYSIS
INDICATION OF POST OP RADIOTHERAPY
Immobilization devices
Conventional planning
Alignment of the Tangential Beam with the Chest Wall Contour
Doses To Heart & Lung By Tangential Fields
Radiation Therapy Bc
This document summarizes evidence on the use of radiation therapy in the management of ductal carcinoma in situ (DCIS) of the breast. It reviews data from four randomized controlled trials showing that the addition of radiation therapy after breast-conserving surgery significantly reduces rates of local recurrence compared to surgery alone, including reductions in both invasive and non-invasive recurrences. It also discusses several non-randomized studies exploring selective use of radiation therapy in patients with favorable tumor characteristics, and ongoing questions about the need for radiation therapy in all patients with DCIS.
Selective Use Of Postoperative Radiotherapy AftEr MastectOmy
The SUPREMO trial aims to determine whether postmastectomy radiotherapy (PMRT) improves outcomes for women with early-stage breast cancer with 1-3 positive lymph nodes. The trial will randomize approximately 3,500 patients to receive either chest wall irradiation or no chest wall irradiation after mastectomy and systemic therapy. The primary outcome is overall survival, with secondary outcomes including disease-free survival, acute/late morbidity, quality of life, and cost-effectiveness. Results from previous trials suggest PMRT may reduce locoregional recurrence and improve survival, especially for those with more positive nodes, but more evidence is still needed.
Management of Early Breast Cancer (by Dr. Akhil Kapoor)
Comprehensive discussion on Management of Early Breast Cancer along with NCCN guidelines.
Slides prepared by Dr. Akhil Kapoor
(Resident, Department of Radiation Oncology,
Acharya Tulsi Regional Cancer Treatment & Research Institute, Bikaner, Rajasthan, India
2 d vs. 3d external beam planning in cervical cancer by nelson mandela
This document compares 2D and 3D treatment planning for cervical cancer patients. It found that using only bony landmarks in 2D planning led to inadequate coverage of the clinical target volume (CTV) in 29 out of 30 patients, with a median CTV coverage of only 95.35%. 3D planning based on computed tomography contouring of the CTV and organs at risk provided much better CTV coverage of 99.55% on average. The study recommends using 3D CT-based planning over conventional 2D planning to improve treatment accuracy for cervical cancer patients.
Management Of Early Stage Ca Cervix [Autosaved]
Carcinoma of the cervix is the second most common cancer in women worldwide. It commonly presents with abnormal vaginal bleeding. Diagnosis is confirmed with biopsy and staging involves imaging tests. Treatment depends on stage, patient factors, and desire for fertility preservation. For early stage disease, options include surgery (radical hysterectomy) or radiation (brachytherapy with external beam radiation). Advanced stages are treated with concurrent chemoradiation. Close follow-up is needed after primary treatment.
Ovary 2
This document discusses several topics related to the treatment of ovarian cancer including adjuvant chemotherapy, assessment of treatment response, and management of recurrent/resistant disease. It summarizes several key studies comparing different chemotherapy regimens for advanced ovarian cancer, including the use of carboplatin versus cisplatin, dose-dense versus conventional schedules, intraperitoneal versus intravenous administration, and the addition of bevacizumab. It also reviews options for recurrent platinum-sensitive and platinum-resistant disease, secondary cytoreduction surgery, and the potential role of targeted therapies, immunotherapy and radiation.
Radiotherapy in carcinoma breast
Radiotherapy in carcinoma breast,interstial brachytherapy in carcinoma breast,indications of radiotherapy in carcinoma breast
Breast Cancer kholy
This document discusses radiation therapy for breast cancer. It provides details on the different types of radiation therapy including external beam radiation therapy and brachytherapy. It describes the different radiation regimens used based on factors like surgery type, tumor size, and lymph node involvement. It also discusses indications, contraindications, and principles of delivering radiation therapy to the breast, chest wall, and regional lymph nodes.
Iort dr kiran
- Intraoperative radiotherapy (IORT) involves delivering a single large radiation dose to the tumor bed during surgery. It allows direct radiation to the target area while sparing surrounding normal tissue. IORT has been used to treat cancers of the rectum, soft tissues, breast, pancreas, and bones. The benefits of IORT include completing radiation therapy in a single session during surgery, convenience for patients by avoiding multiple follow-up radiation sessions, and decreased side effects compared to conventional radiation therapy. Effective IORT requires a multidisciplinary team approach between surgeons, radiation oncologists, medical physicists, and other specialists.
Rectal Cancer
This document discusses advances in non-invasive treatments for rectal cancer, allowing some patients to avoid colostomies and radical surgery. It describes a recent study of 36 patients with low-lying rectal cancer who received pre-operative radiation and chemotherapy, followed by surgery. For 5 patients (14%), the pre-operative treatment eliminated the cancer completely. Most patients (77%) were able to have a less invasive surgery called a low anterior resection, preserving their anus and avoiding a colostomy. The study concludes this approach may be a good alternative to more invasive surgeries for selected rectal cancer patients.
Chemotherapy of breast cancer
This document provides an overview of chemotherapy for breast cancer. It begins by introducing breast cancer as the second leading cause of cancer deaths in women. It then discusses the history and improvements in diagnosis and treatment over the last 30 years, moving from radical mastectomies to more targeted surgical options. The rest of the document covers risk factors, clinical manifestations, diagnosis, various treatment options including surgery, radiation therapy, chemotherapy and hormone therapy, and side effects of treatment.
More Related Content
What's hot
Radiotherapy In Early Breast Cancer
This document summarizes the use of radiotherapy in early breast cancer treatment. It discusses how breast-conserving therapy with radiotherapy is as effective as mastectomy, and how radiotherapy reduces local recurrence when used as part of breast-conserving surgery for ductal carcinoma in situ. It also describes different radiotherapy techniques for early invasive breast cancer including whole breast irradiation, tumor bed boosts, and accelerated partial breast irradiation.
RT breast apbi
1) The document discusses various techniques for radiation therapy treatment planning and delivery for breast cancer, including tangential field planning, supraclavicular field matching, electron boosts, and accelerated partial breast irradiation.
2) Techniques for accelerated partial breast irradiation discussed include multi-catheter interstitial brachytherapy, balloon-based brachytherapy using devices like Mammosite, and external beam radiation therapy.
3) Factors that determine suitability for accelerated partial breast irradiation include patient age, tumor size and characteristics, and nodal involvement. Dosage schedules and advantages and disadvantages of different techniques are also reviewed.
RADIOTHERAPY FOR BREAST CANCER
1. The document discusses locally advanced breast cancer and the role of radiotherapy. It outlines the anatomy, target volumes, organs at risk and response assessment using tools like MRI.
2. Postmastectomy radiotherapy can reduce the risk of local recurrence by 72% and increase survival rates. The risk of local recurrence is higher with larger tumor size and more positive lymph nodes.
3. The use of neoadjuvant chemotherapy and radiotherapy after mastectomy further reduces the risk of local-regional recurrence compared to no radiotherapy, especially in patients with more advanced clinical stage.
ADJUTANT RADIOTHERAPY IN BREAST CANCER
This document discusses the evidence for adjuvant radiotherapy in breast cancer treatment. It finds that radiotherapy after breast-conserving surgery or mastectomy significantly reduces the risk of local recurrence and improves overall survival. For patients undergoing breast-conserving surgery, radiotherapy reduces the 10-year cumulative incidence of recurrence in the ipsilateral breast from 39.2% to 14.3%. Post-mastectomy radiotherapy is recommended for patients with ≥4 positive lymph nodes or 1-3 positive lymph nodes with high-risk features, as it lowers the risk of locoregional recurrence and improves overall survival. The timing, techniques, target volumes, and indications for radiotherapy are also outlined based on clinical evidence and guidelines.
Radiotherapy Breast Cancer
Radiotherapy is commonly used to treat breast cancer. Proper patient positioning and immobilization are crucial to accurately deliver the prescribed radiation dose while sparing surrounding healthy tissues. Treatment typically involves two tangential photon beams shaped to the breast tissue. Three-dimensional conformal radiotherapy may improve dose uniformity in the breast and reduce radiation exposure to the heart and lungs. Intensity-modulated radiation therapy provides further dosimetric advantages such as enhanced dose homogeneity and organ sparing, though it may also increase low-dose exposure. Forward-planned IMRT techniques like field-in-field are commonly used for breast radiotherapy due to benefits such as improved dosimetry and reduced planning/treatment time compared to inverse planning.
2012_Breast Cancer and Coronary Artery Disease
This document discusses radiation therapy for breast cancer and its potential effects on the heart and coronary arteries. It provides an overview of the pathophysiology of radiation-induced cardiac toxicity, including microangiopathy of small vessels, macroangiopathy of coronary arteries, and fibrosis. It also summarizes several studies that found increased risks of ischemic heart disease, pericarditis, and valvular disease in patients receiving left-sided breast radiation compared to right-sided radiation. Newer radiation techniques using methods like deep inspiration breath hold and intensity-modulated radiation therapy can help reduce radiation doses to the heart.
Breast HDR interstitial brachytherapy
This document provides information on breast interstitial brachytherapy workshop presented by Ali Bagheri M.D. and Cynthia Aristei M.D. It discusses clinical aspects of accelerated partial breast irradiation (APBI) including patient selection, techniques such as multi-catheter interstitial brachytherapy and balloon-based brachytherapy. It also covers target delineation, dose-fractionation schedules, dose constraints, and provides an example case of a 65 year old female who underwent lumpectomy and is a candidate for APBI using interstitial brachytherapy based on her pathology report and imaging.
San Antonio Breast Cancer Symposium 2007 Highlights – Radiotherapy
The document summarizes several studies presented at the 2007 San Antonio Breast Cancer Symposium on radiotherapy techniques:
1) The Cambridge Breast IMRT Trial found IMRT significantly reduced hot and cold spots compared to standard radiotherapy for breast cancer.
2) A trial of 224 patients found prone positioning enabled better sparing of the heart and lungs in most cases compared to supine.
3) The START trials found hypofractionated whole breast radiotherapy schedules were as effective as standard schedules with no increase in long-term morbidity.
intrabeam intraoperative radiotherapy
The document discusses intrabeam intraoperative radiotherapy (IORT) for breast cancer. It summarizes the TARGIT-A clinical trial which found IORT using the INTRABEAM system to be non-inferior to whole breast external beam radiotherapy for selected early-stage breast cancer patients. The INTRABEAM system delivers a targeted single fraction of low-energy X-rays directly to the tumor bed during lumpectomy surgery, shortening treatment time compared to the standard 5-6 weeks of external beam radiotherapy. The technique aims to sterilize the tumor bed while sparing surrounding healthy tissue from radiation exposure.
Marc Wigoda : Radiotherapy of the Axilla in Early Breast Cancer : When and H...
Marc Wigoda : Radiotherapy of the Axilla in Early Breast Cancer : When and H...breastcancerupdatecongress
1. Radiotherapy of the axilla can be an effective alternative to axillary lymph node dissection for early breast cancer patients who are sentinel lymph node positive. Two randomized trials found similar survival and recurrence rates with radiotherapy compared to lymph node dissection.
2. Radiotherapy fields may be limited to just the breast tissue and do not require an additional "axillary/supraclavicular" field. Classical tangential fields that treat 50-80% of axillary nodes are sufficient.
3. For sentinel lymph node positive patients, radiotherapy results in fewer side effects like lymphedema compared to lymph node dissection. Radiotherapy is as effective as surgery for these patients.radiation therapy in ca breast
EBCTCG METAANALYSIS
INDICATION OF POST OP RADIOTHERAPY
Immobilization devices
Conventional planning
Alignment of the Tangential Beam with the Chest Wall Contour
Doses To Heart & Lung By Tangential Fields
Radiation Therapy Bc
This document summarizes evidence on the use of radiation therapy in the management of ductal carcinoma in situ (DCIS) of the breast. It reviews data from four randomized controlled trials showing that the addition of radiation therapy after breast-conserving surgery significantly reduces rates of local recurrence compared to surgery alone, including reductions in both invasive and non-invasive recurrences. It also discusses several non-randomized studies exploring selective use of radiation therapy in patients with favorable tumor characteristics, and ongoing questions about the need for radiation therapy in all patients with DCIS.
Selective Use Of Postoperative Radiotherapy AftEr MastectOmy
The SUPREMO trial aims to determine whether postmastectomy radiotherapy (PMRT) improves outcomes for women with early-stage breast cancer with 1-3 positive lymph nodes. The trial will randomize approximately 3,500 patients to receive either chest wall irradiation or no chest wall irradiation after mastectomy and systemic therapy. The primary outcome is overall survival, with secondary outcomes including disease-free survival, acute/late morbidity, quality of life, and cost-effectiveness. Results from previous trials suggest PMRT may reduce locoregional recurrence and improve survival, especially for those with more positive nodes, but more evidence is still needed.
Management of Early Breast Cancer (by Dr. Akhil Kapoor)
Comprehensive discussion on Management of Early Breast Cancer along with NCCN guidelines.
Slides prepared by Dr. Akhil Kapoor
(Resident, Department of Radiation Oncology,
Acharya Tulsi Regional Cancer Treatment & Research Institute, Bikaner, Rajasthan, India
2 d vs. 3d external beam planning in cervical cancer by nelson mandela
This document compares 2D and 3D treatment planning for cervical cancer patients. It found that using only bony landmarks in 2D planning led to inadequate coverage of the clinical target volume (CTV) in 29 out of 30 patients, with a median CTV coverage of only 95.35%. 3D planning based on computed tomography contouring of the CTV and organs at risk provided much better CTV coverage of 99.55% on average. The study recommends using 3D CT-based planning over conventional 2D planning to improve treatment accuracy for cervical cancer patients.
Management Of Early Stage Ca Cervix [Autosaved]
Carcinoma of the cervix is the second most common cancer in women worldwide. It commonly presents with abnormal vaginal bleeding. Diagnosis is confirmed with biopsy and staging involves imaging tests. Treatment depends on stage, patient factors, and desire for fertility preservation. For early stage disease, options include surgery (radical hysterectomy) or radiation (brachytherapy with external beam radiation). Advanced stages are treated with concurrent chemoradiation. Close follow-up is needed after primary treatment.
Ovary 2
This document discusses several topics related to the treatment of ovarian cancer including adjuvant chemotherapy, assessment of treatment response, and management of recurrent/resistant disease. It summarizes several key studies comparing different chemotherapy regimens for advanced ovarian cancer, including the use of carboplatin versus cisplatin, dose-dense versus conventional schedules, intraperitoneal versus intravenous administration, and the addition of bevacizumab. It also reviews options for recurrent platinum-sensitive and platinum-resistant disease, secondary cytoreduction surgery, and the potential role of targeted therapies, immunotherapy and radiation.
Radiotherapy in carcinoma breast
Radiotherapy in carcinoma breast,interstial brachytherapy in carcinoma breast,indications of radiotherapy in carcinoma breast
Breast Cancer kholy
This document discusses radiation therapy for breast cancer. It provides details on the different types of radiation therapy including external beam radiation therapy and brachytherapy. It describes the different radiation regimens used based on factors like surgery type, tumor size, and lymph node involvement. It also discusses indications, contraindications, and principles of delivering radiation therapy to the breast, chest wall, and regional lymph nodes.
Iort dr kiran
- Intraoperative radiotherapy (IORT) involves delivering a single large radiation dose to the tumor bed during surgery. It allows direct radiation to the target area while sparing surrounding normal tissue. IORT has been used to treat cancers of the rectum, soft tissues, breast, pancreas, and bones. The benefits of IORT include completing radiation therapy in a single session during surgery, convenience for patients by avoiding multiple follow-up radiation sessions, and decreased side effects compared to conventional radiation therapy. Effective IORT requires a multidisciplinary team approach between surgeons, radiation oncologists, medical physicists, and other specialists.
What's hot (20)
San Antonio Breast Cancer Symposium 2007 Highlights – Radiotherapy
San Antonio Breast Cancer Symposium 2007 Highlights – Radiotherapy
Marc Wigoda : Radiotherapy of the Axilla in Early Breast Cancer : When and H...
Marc Wigoda : Radiotherapy of the Axilla in Early Breast Cancer : When and H...
Selective Use Of Postoperative Radiotherapy AftEr MastectOmy
Selective Use Of Postoperative Radiotherapy AftEr MastectOmy
Management of Early Breast Cancer (by Dr. Akhil Kapoor)
Management of Early Breast Cancer (by Dr. Akhil Kapoor)
2 d vs. 3d external beam planning in cervical cancer by nelson mandela
2 d vs. 3d external beam planning in cervical cancer by nelson mandela
Similar to Breast cancer brachytherapy
Rectal Cancer
This document discusses advances in non-invasive treatments for rectal cancer, allowing some patients to avoid colostomies and radical surgery. It describes a recent study of 36 patients with low-lying rectal cancer who received pre-operative radiation and chemotherapy, followed by surgery. For 5 patients (14%), the pre-operative treatment eliminated the cancer completely. Most patients (77%) were able to have a less invasive surgery called a low anterior resection, preserving their anus and avoiding a colostomy. The study concludes this approach may be a good alternative to more invasive surgeries for selected rectal cancer patients.
Chemotherapy of breast cancer
This document provides an overview of chemotherapy for breast cancer. It begins by introducing breast cancer as the second leading cause of cancer deaths in women. It then discusses the history and improvements in diagnosis and treatment over the last 30 years, moving from radical mastectomies to more targeted surgical options. The rest of the document covers risk factors, clinical manifestations, diagnosis, various treatment options including surgery, radiation therapy, chemotherapy and hormone therapy, and side effects of treatment.
Brachytherapy india
Economical, low cost, successful brachytherapy surgery in India an advantage for oversea patients coming through IndianMedGuru a leading medical tourism company.
Let's Talk About It: Breast Cancer (The History and Advances in Radiation The...
We know that radiation therapy (RT) is an important component of breast cancer treatment that reduces local recurrence and improves survival after breast conservation. Have you ever wondered about the history of radiation and the role of radiation boosts to the primary tumor site? How do radiation oncologists determine who should receive radiation therapy or not? Join us as we discuss the history and advances in radiation therapy with Karen Godette, MD, Medical Director of the Radiation Oncology Department at Emory University Hospital in Midtown and Associate Professor, Department of Radiation Oncology at Emory University School of Medicine in Atlanta, GA.
Oncoplastic breast surgery
The normal breast consists of milk-producing glands that are
connected to the surface of the skin at the nipple by narrow
ducts. The glands and ducts are supported by connective tissue
made up of fat and fibrous material. Blood vessels, nerves, and
lymphatic channels to the lymph nodes make up most of the
remaining breast tissue.
What Is Breast Cancer?
The normal breast consists of milk-producing glands that are
connected to the surface of the skin at the nipple by narrow
ducts. The glands and ducts are supported by connective tissue
made up of fat and fibrous material. Blood vessels, nerves, and
lymphatic channels to the lymph nodes make up most of the
remaining breast tissue.
Advancements in Rectal Cancer Treatments
In this presentation, Dr. Deborah Schrag, Medical Oncologist from Dana Farber Cancer Institute covers therapy options, surgery options, and radiation options, that are specific to rectal cancer patients. She also touches on the importance of clinical trials for this population, and highlights a few trials in research that she finds most interesting.
More information related to our Webinar Series can be found at http://fightcolorectalcancer.org/about/webinars
Organ preservation in kenyan breast cancer patients by peter bird
Breast cancer poses a significant burden in developing countries like Kenya. At Kijabe Hospital in Kenya, most breast cancer patients present with locally advanced disease and the median age of patients is younger than in Western countries. Treatment options are limited by costs and available resources. For poorer patients, treatment typically involves a mastectomy with adjuvant therapies if the tumor can be removed, while wealthier patients may receive breast conserving surgery and more comprehensive adjuvant treatment. Radiotherapy, an important part of breast conservation, is often not available locally and requires travel to Nairobi. Management strategies in low-resource settings must be tailored to the economic realities of individual patients.
Organ preservation in kenyan breast cancer patients by peter bird
Breast cancer poses a significant burden in developing countries like Kenya. At Kijabe Hospital in Kenya, most breast cancer patients present with locally advanced disease and the median age of patients is younger than in Western countries. Treatment options are limited by costs and available resources. For poorer patients, treatment typically involves a mastectomy with adjuvant therapies if the tumor can be removed, while wealthier patients may receive breast conserving surgery and more comprehensive adjuvant treatment. Radiotherapy, an important part of breast conservation, is often not available locally and requires travel to Nairobi. Management strategies in low-resource settings must be tailored to the economic realities of individual patients.
Breast cancer reconstruction surgery
Breast cancer Reconstruction Surgery- Breast cancer Reconstruction procedures provides correction of the absence or abnormality of the breast for whatever reason - be it cancer, infection, trauma or congenital.
HEMANTH ADJUVANT This is adjuvant therapy utilised for education purpose(1) (...
HEMANTH ADJUVANT This is adjuvant therapy utilised for education purpose(1) (...surimallasrinivasgan
This document discusses adjuvant treatment for breast cancer, including metastatic breast cancer. It covers radiotherapy techniques, indications, target volumes, and dose schedules. It also discusses neoadjuvant systemic therapy and adjuvant systemic therapy including chemotherapy, targeted therapy, and hormonal therapy. The goal of adjuvant therapy is to eradicate micrometastases and reduce the risk of recurrence after primary treatment.Therapy 1.pptx
Brachytherapy is a type of radiation therapy where radioactive sources are placed inside or next to a tumor to deliver a high dose of radiation directly to cancer cells. There are two main types: internal brachytherapy involves placing radioactive sources inside the body, while surface brachytherapy places sources on the skin. Brachytherapy works by delivering a high radiation dose near the source which decreases rapidly with distance, and it is used to treat cancers like breast, lung, and head/neck cancers.
Gynecology 5th year, 10th lecture (Dr. Hanaa)
Cervical cancer is the most common form of cancer in women in developing countries. It is caused by certain types of human papillomavirus (HPV) infection and regular Pap screening can detect abnormal cell changes before they become cancerous. Treatment options include surgery, radiation therapy, and chemotherapy depending on the stage of cancer.
Mastectomy.docx
This document summarizes the surgical procedure of a modified radical mastectomy. It involves removing the entire breast, including the skin, nipple, and most axillary lymph nodes, while sparing the pectoralis major muscle. Indications include breast cancer that is not a candidate for breast conservation, such as inflammatory breast cancer or inability to obtain clear margins. The procedure involves making skin flaps, removing the breast tissue and pectoral fascia, and performing an axillary lymph node dissection through the same incision. Postoperative care focuses on preventing complications like seroma, infection, and lymphedema.
Brachytherapy
This document discusses brachytherapy, a type of radiation therapy where radioactive material is placed directly inside the body near the tumor being treated. It begins by explaining the two major categories of radiation therapy: external-beam therapy where a machine emits radiation from outside the body, and brachytherapy where radioactive sources are placed inside the body. It then provides details on brachytherapy, including how it works from inside the body compared to external beam therapy, common radiation sources used, and the typical procedure involving planning, applicator insertion, treatment delivery, and removal of sources.
ROJoson PEP Talk: Can one skip RADIOTHERAPY in Breast Cancer Treatment?
ROJoson PEP Talk: Can one skip RADIOTHERAPY in Breast Cancer Treatment?
Ncd group presentation
The document proposes a project to screen and control breast and cervical cancer in Rajshahi District. The project aims to educate and motivate women aged 40-64 to undergo breast cancer screening via mammography and women aged 21-64 to undergo cervical cancer screening via visual inspection with acetic acid. It will establish temporary screening camps in 11 upazilas to conduct screening tests and refer positive cases for treatment. The 6-month project aims to screen 342 women and will be evaluated to assess its effectiveness and make improvements. An estimated budget of 15 lakh BDT is proposed to cover direct and indirect costs.
Cancer Project in Lao PDR
The document discusses cancer treatment facilities and incidence in Lao PDR. It notes that Lao PDR does not have cancer registries or adequate cancer treatment facilities. Patients must travel to neighboring countries for surgery, chemotherapy or radiotherapy. The most common cancers are estimated to be lung, stomach, liver and colorectal cancers in males and breast, cervical, stomach and colorectal cancers in females based on data from Vietnam. The document calls for increasing cancer awareness, training medical professionals, and establishing basic cancer treatment facilities in Lao PDR.
Top 10 Pancreatic Cancer Surgery Hospitals in India
Top 10 Pancreatic Cancer Surgery Hospitals in IndiaAnswering Patient’s Queries – One At A Time!: Part 1
Pancreatic cancer ranks as the 12th most prevalent cancer globally. It occupies the 12th position in men and the 11th position among women among the most widespread cancers. Globally, almost 496,000 people are diagnosed with Pancreatic yearly, and around 433,000 die yearly. India is home to several proficient oncologists who have successfully restricted the growth of pancreatic cancer and its symptoms, thus helping people to live a long life. The Pancreatic Cancer Surgery Hospitals in India house one of the most renowned experts in the medical field and, provide the best medical care available.Pancreatic Cancer Treatment in India: The Journey of Courage and Healing
Pancreatic Cancer Treatment in India: The Journey of Courage and HealingAnswering Patient’s Queries – One At A Time!: Part 1
Pancreatic cancer is a devastating disease that affects thousands of people around the world, and India is no exception. However, in recent years, there have been significant advancements in pancreatic cancer treatment in India, offering new hope to patients and their families. From innovative surgical techniques to targeted therapies and personalized medicine, the journey of courage and healing for pancreatic cancer patients in India has come a long way.Similar to Breast cancer brachytherapy (20)
Let's Talk About It: Breast Cancer (The History and Advances in Radiation The...
Let's Talk About It: Breast Cancer (The History and Advances in Radiation The...
Organ preservation in kenyan breast cancer patients by peter bird
Organ preservation in kenyan breast cancer patients by peter bird
Organ preservation in kenyan breast cancer patients by peter bird
Organ preservation in kenyan breast cancer patients by peter bird
HEMANTH ADJUVANT This is adjuvant therapy utilised for education purpose(1) (...
HEMANTH ADJUVANT This is adjuvant therapy utilised for education purpose(1) (...
ROJoson PEP Talk: Can one skip RADIOTHERAPY in Breast Cancer Treatment?
ROJoson PEP Talk: Can one skip RADIOTHERAPY in Breast Cancer Treatment?
Top 10 Pancreatic Cancer Surgery Hospitals in India
Top 10 Pancreatic Cancer Surgery Hospitals in India
Pancreatic Cancer Treatment in India: The Journey of Courage and Healing
Pancreatic Cancer Treatment in India: The Journey of Courage and Healing
Recently uploaded
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Do you have abnormal smell after periods? It may be vaginitis. Do not worry, herbal medicine Fuyan Pill can help you get a cure.
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Explore the benefits of combining Ayurveda with conventional Parkinson's treatments. Learn how a holistic approach can manage symptoms, enhance well-being, and balance body energies. Discover the steps to safely integrate Ayurvedic practices into your Parkinson’s care plan, including expert guidance on diet, herbal remedies, and lifestyle modifications.
share - Lions, tigers, AI and health misinformation, oh my!.pptx
• Pitfalls and pivots needed to use AI effectively in public health
• Evidence-based strategies to address health misinformation effectively
• Building trust with communities online and offline
• Equipping health professionals to address questions, concerns and health misinformation
• Assessing risk and mitigating harm from adverse health narratives in communities, health workforce and health system
Histopathology of Rheumatoid Arthritis: Visual treat
Histopathology of Rheumatoid Arthritis: Visual treat
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis is an increasing cause of morbidity among the elderly.
In this document , a brief outline of osteoporosis is given , including the risk factors of osteoporosis fractures , the indications for testing bone mineral density and the management of osteoporosis
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
- Video recording of this lecture in English language: https://youtu.be/kqbnxVAZs-0
- Video recording of this lecture in Arabic language: https://youtu.be/SINlygW1Mpc
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
pathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathology
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
It includes regulation of combination products and medical devices. FDA and industry liaisons.
Identifying Major Symptoms of Slip Disc.
Our backs are like superheroes, holding us up and helping us move around. But sometimes, even superheroes can get hurt. That’s where slip discs come in.
Hiranandani Hospital Powai News [Read Now].pdf
Hiranandani Hospital in Powai, Mumbai, is a premier healthcare institution that has been serving the community with exceptional medical care since its establishment. As a part of the renowned Hiranandani Group, the hospital is committed to delivering world-class healthcare services across a wide range of specialties, including kidney transplantation. With its state-of-the-art facilities, advanced medical technology, and a team of highly skilled healthcare professionals, Hiranandani Hospital has earned a reputation as a trusted name in the healthcare industry. The hospital's patient-centric approach, coupled with its focus on innovation and excellence, ensures that patients receive the highest standard of care in a compassionate and supportive environment.
The Electrocardiogram - Physiologic Principles
These lecture slides, by Dr Sidra Arshad, offer a quick overview of the physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar lead (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
6. Describe the flow of current around the heart during the cardiac cycle
7. Discuss the placement and polarity of the leads of electrocardiograph
8. Describe the normal electrocardiograms recorded from the limb leads and explain the physiological basis of the different records that are obtained
9. Define mean electrical vector (axis) of the heart and give the normal range
10. Define the mean QRS vector
11. Describe the axes of leads (hexagonal reference system)
12. Comprehend the vectorial analysis of the normal ECG
13. Determine the mean electrical axis of the ventricular QRS and appreciate the mean axis deviation
14. Explain the concepts of current of injury, J point, and their significance
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. Chapter 3, Cardiology Explained, https://www.ncbi.nlm.nih.gov/books/NBK2214/
7. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
Recently uploaded (20)
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Outbreak management including quarantine, isolation, contact.pptx
Outbreak management including quarantine, isolation, contact.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
Histopathology of Rheumatoid Arthritis: Visual treat
Histopathology of Rheumatoid Arthritis: Visual treat
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
pathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathology
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Breast cancer brachytherapy
- 1. Arizona Breast Cancer Specialists
- 2. Brachytherapy, also known as sealed source radiotherapy or endocurietherapy, is a form of radiotherapy where a radioactive source is placed inside or next to the area requiring treatment. Brachytherapy has been commonly used for a long time to treat localized prostate cancer, cervical cancer and cancers of the head and neck.
- 3. Thepreferred treatment for early stage breast cancer is surgical removal of the cancerous lump (lumpectomy) followed by radiation therapy to the breast; radiation therapy following this eliminates the invisibly small deposits of cancer that can remain in the breast after lumpectomy.
- 4. Radiation treatments are given to kill off any possible remaining cancer cells in the breast. Radiation is done to help prevent a recurrence, or return, of breast cancer and can be given with external or internal radiation.
- 5. External beam radiation begins Breast brachytherapy is a 5-day four to six weeks after surgery. radiation therapy alternative for Patients receive one treatment a women with early stage breast day for six to seven weeks. It is cancer. very successful in preventing recurrence of cancer in the breast, but many women find the long duration of treatment to be burdensome. External beam radiation therapy is safe and very effective, but can take over six weeks of daily treatment.
- 6. Breast brachytherapy, or partial breast irradiation (PBI), has been researched and tested by Dr. Robert Kuske since 1991 as a treatment method after lumpectomy. He has advanced the techniques and technology, and championed the research bringing breast brachytherapy to where it is today. He has remained totally committed to his patients, who let him know in no uncertain terms that they wanted a shorter more convenient alternative with less radiation exposure to surrounding healthy tissues.
- 7. Arizona Breast Cancer Specialists (ABCs) is the first clinic in the world dedicated to exclusively treating women with breast cancer with radiation. It is led by Dr. Robert Kuske and Dr. Coral Quiet, Radiation Oncologists who specialize in the treatment of breast cancer. Together, they have 43 years of experience treating this disease.
- 8. Brachytherapy for breast cancer: http:// www.arizona-breast-cancer-specialists.com/ brachytherapy/all-about-what-is- brachytherapy.html Dr. Robert Kuske: http://www.arizona-breast- cancer-specialists.com/arizona-breast-cancer- specialists-doctors/doctor-robert-kuske.html Dr. Coral Quiet: http://www.arizona-breast- cancer-specialists.com/arizona-breast-cancer- specialists-doctors/doctor-coral-quiet.html